Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.
about
Extended-spectrum beta-lactamases: a clinical updateExtended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamasesThe role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial OriginLaboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of JapanOutbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals.Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico.Carbapenemase-producing Enterobacteriaceae, U.S. rivers.Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial DominanceEnterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) colonization as a risk factor for developing ESBL infections in pediatric cardiac surgery patients: "retrospective cohort study".Spread of TEM, VIM, SHV, and CTX-M β-Lactamases in Imipenem-Resistant Gram-Negative Bacilli Isolated from Egyptian Hospitals.First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital.Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.In vivo acquisition of high-level resistance to imipenem in Escherichia coliAmpC beta-lactamases.Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.Antimicrobial susceptibility testing: a primer for clinicians.The strategy of antibiotic use in critically ill neutropenic patientsEmergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates.Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganiiOccurrence of Plasmid-Mediated AmpC β-Lactamases Among Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Tertiary Care Hospital in Bangalore.Therapeutic challenges of ESBLS and AmpC beta-lactamase producers in a tertiary care center.First report of Salmonella isolates with the DHA-1 AmpC beta-lactamase in the United Kingdom.Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient.Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremiaAmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases.Genotypic Identification of AmpC β-Lactamases Production in Gram-Negative Bacilli Isolates.Phenotypic and molecular characterization of plasmid mediated AmpC β-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals.Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.Ultrastructural Changes in Clinical and Microbiota Isolates of Klebsiella pneumoniae Carriers of Genes bla SHV, bla TEM, bla CTX-M, or bla KPC When Subject to β-Lactam Antibiotics.Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals.
P2860
Q24534999-611364F1-693C-4570-A7B8-1489F5237FB6Q24650618-02326128-CCE0-4E28-8DBF-9AEDFE616B4BQ30300020-F4021C77-48D9-4130-913A-E6C75311A3BEQ33736461-FC4889BB-B123-4CFE-BFD3-4325A75861DBQ34120497-7A8931CC-0F8A-41B8-AAFB-976A1335DB06Q34370760-6B371FC6-0AB1-4C7B-B3B1-7D7D3E710623Q34502934-FBAA0B8E-30B4-4F4D-9B61-B1D6FE658662Q35073335-21B5BBA5-E540-4886-8F87-E930A4E8A2E1Q35356144-29E9BC38-B7FC-407E-95F4-92DEAC932245Q35867419-F2A217BC-3D91-4984-90A5-372352256A1DQ35873280-6407A859-0892-42E2-85F9-502D95AC20E1Q35917401-2CFA0CBE-41DD-4C9A-8311-C1CE978F9065Q36076066-6FDED63E-0F44-4632-8937-85AA41670077Q36327254-AE1FFA14-11FF-45C9-BC11-AC5BC380F552Q36795471-23EA805D-F35E-4651-9EE5-708ED025F3B0Q37040812-81F15A1C-3A8B-4CF4-9D52-B8EF99C2C306Q37051380-451E6C99-6761-4CBA-89FD-92DA09F4C7CCQ37156252-3666657F-67F1-404C-9D51-98D8D8CA9463Q37366249-94C607EC-8D87-404D-805F-D12725EE3734Q37598717-4FF1E842-2A2D-492F-A037-923E60CD72F8Q37621552-8E157FB9-362E-47D9-8EC3-4C9808242503Q37929895-3BDAA8E8-D8FB-44DD-B46A-D015B8290353Q39687830-898A2CA1-2323-4BC5-B189-64CFEB520536Q40469507-6E8E8F8D-0C59-42B3-AE9F-2C24382B47AFQ41429594-90AC685C-926B-423D-851E-3A1E2B899A76Q41761814-8326245F-3BF7-4C75-9532-62CE1FCA4E7FQ42201691-16B298BF-C028-43DB-A46A-5D6B6D155CEDQ42287921-7940672A-C028-4376-BD56-555024D5BBE7Q42416893-4B9616EA-F090-4549-BDA9-CA0B0BF86B3CQ42425506-5B60C50A-6E47-4784-84EB-13181FB20C2EQ42537148-0E4A436F-4C5B-4577-B285-BD3C6C11D0B2Q42593304-146C9515-01D3-4528-9F91-BF4BF5EB89D6Q42819007-FF3FDE7D-D6D2-445D-9A12-EF61D7BB60D7Q43479674-80291B27-4819-482A-B73F-9084C88DDC2CQ45982863-65D23B68-D3AF-48F6-A8AE-969CBFE7D6EEQ46510582-5F05C730-B70E-4650-A112-A61A84F743D1Q53303392-DBB454D2-F0A7-4CA7-8A9D-67FF438A3FACQ54432999-E1D60358-9B65-4A48-B152-B4365AFF4B13
P2860
Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Occurrence of newer beta-lacta ...... olates from 24 U.S. hospitals.
@en
type
label
Occurrence of newer beta-lacta ...... olates from 24 U.S. hospitals.
@en
prefLabel
Occurrence of newer beta-lacta ...... olates from 24 U.S. hospitals.
@en
P2093
P2860
P1476
Occurrence of newer beta-lacta ...... olates from 24 U.S. hospitals.
@en
P2093
Ellen Smith Moland
Jason Ourada
Jennifer A Black
Kenneth S Thomson
Mark D Reisbig
Nancy D Hanson
P2860
P304
P356
10.1128/AAC.46.12.3837-3842.2002
P407
P577
2002-12-01T00:00:00Z